Is Cryoport, Inc. (CYRX) a Buy, Sell, or Hold?
NASDAQ : CYRX
Cryoport, Inc.
$16.51 USD
$0.02 (0.12%)
- Volume
- 702.12K
- Average Volume
- 810.56K
- Market Capitalization
- $832.14M
- P/E Ratio
- 11.55
- Dividend Yield
- 0.00%
- Price Target
- $16.00
- Year High
- $16.89
- Year Low
- $6.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.09
Company Overview
NASDAQ
Jerrell W. Shelton
Integrated Freight & Logistics
Industrials
CYRX
738
US
USD
Liquidity Metrics
0.47
2.09
2.00
1.21
0.00
Sales & Valuation
$176.18M
4.55
1.66
-34.16
-0.49
Profitability
$1.4
$78.3M
42.18%
-19.13%
16.16%
10.10%
P/E Metrics
11.55
0.07
0.07
Analyst Price Target & Rating
$16.00
$20.00
$12.00
4/5
19 Analysts
3.19%
Poll Results
About Cryoport, Inc. (NASDAQ:CYRX) Stock
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of bi ... ological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
2026-06-25 08:00:00
IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Services Supporting Verismo's Novel Multi-chain KIR-CAR Programs for Lead Candidates SynKIR™-110 and SynKIR™-310 NASHVILLE, Tenn., June 25, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that Cryoport Systems' IntegriCell® cryopreservation services have been selected by Verismo Therapeutics, a clinical-stage CAR T cell therapy company pioneering a novel multi-chain KIR-CAR platform technology for the treatment of solid tumors (SynKIR™-110) and B cell associated disorders and malignancies (SynKIR™-310).
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
2026-05-05 01:53:22
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
2026-05-04 18:50:27
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.22 per share a year ago.
Cryoport Reports First Quarter 2026 Financial Results
2026-05-04 16:05:00
First quarter revenue grew 16% year-over-year to $47.8 million Commercial cell and gene therapy (CGT) revenue grew 26% year-over-year to $9.1 million, reflecting continued expansion in approved CGT programs Life Sciences Services revenue increased 18% year-over-year, led by 21% growth in BioStorage/BioServices Life Sciences Products revenue increased 15% year-over-year, driven by strong demand for cryogenic systems Supporting a record 766 global clinical trials and 21 commercially approved CGTs as of March 31, 2026 Company raises full-year revenue guidance to $192 million - $196 million NASHVILLE, Tenn., May 4, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its first quarter (Q1) of 2026.
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
2026-04-20 16:05:00
NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the first quarter ended March 31, 2026 on Monday, May 4, 2026 after U.S. markets close.
Frequently Asked Questions
-
What is the current Cryoport, Inc. (CYRX) stock price?
-
Cryoport, Inc.(NASDAQ:CYRX) stock price is $16.51 in the last trading session. During the trading session, CYRX stock reached the peak price of $16.89 while $6.69 was the lowest point it dropped to. The percentage change in CYRX stock occurred in the recent session was 0.12% while the dollar amount for the price change in CYRX stock was $0.02.
-
CYRX's industry and sector of operation?
-
The NASDAQ listed CYRX is part of Integrated Freight & Logistics industry that operates in the broader Industrials sector.
-
Who are the executives of CYRX?
-
Edward J. Zecchini | Senior Vice President and Chief Digital & Technology Officer
Jerrell W. Shelton | Chairman, President & Chief Executive Officer
Robert S. Stefanovich | Senior Vice President, Chief Financial Officer, Treasurer & Chief Administrative Officer
Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC
Thomas J. Heinzen | Vice President of Corporate Development & Investor Relations -
How many employees does CYRX have?
-
Number of CYRX employees currently stands at 738. CYRX operates from 112 Westwood Place, Brentwood, TN 37027, US.
-
Link for CYRX official website?
-
Official Website of CYRX is: https://www.cryoportinc.com
-
How do I contact CYRX?
-
CYRX could be contacted at phone #949 470 2300 and can also be accessed through its website. CYRX operates from 112 Westwood Place, Brentwood, TN 37027, US.
-
How many shares of CYRX are traded daily?
-
The average number of CYRX shares traded daily for last 3 months was 810.56K.
-
What is the market cap of CYRX currently?
-
The market value of CYRX currently stands at $832.14M with its latest stock price at $16.51